Skip to content
Search

Latest Stories

Speculation about Kim Kardashian's weight loss leads to soaring demand for vital diabetes drug

A TikTok-fuelled stampede for the obesity drug has now led to a global shortage.

Speculation about Kim Kardashian's weight loss leads to soaring demand for vital diabetes drug

In February, the National Institute for Health, and Care Excellence (NICE) approved a weekly jab for obese patients with weight-related diseases, such as type 2 diabetes, or for those at high risk of a heart attack, as losing weight can help protect against these health issues.

However, when in May, reality TV star Kim Kardashian revealed that she had lost 16 lbs in three weeks to fit into a dress that once belonged to Marilyn Monroe, rumours began to circulate that she had used the drug semaglutide which is licensed for use only in those who are obese and suffering with health problems, the Daily Mail reports.


Speculation about Kardashian's weight loss led to high demand for the drug and a TikTok-fuelled stampede for the obesity drug has now led to a global shortage, leaving patients with severe health problems such as type 2 diabetes without the crucial treatment.

Though Kardashian has never commented on the claims, in one TikTok clip, viewed more than a million times, an evangelical patient speculates, ‘In my opinion, Kim’s drastic weight loss could be due to something like [semaglutide]… I might be wrong. These [medicines] are tools for people to completely metabolically change their bodies.’

The medication semaglutide, known by brand names Ozempic and Wegovy, is considered to be a major breakthrough, helping those who take it to shed almost a fifth of their weight.

Therefore, the hashtag #ozempic has garnered more than 270 million views on the social media platform, with hundreds of millions of views for #semaglutide, #wegovy, and similar hashtags.

In October, entrepreneur Elon Musk too had claimed on Twitter that he had lost weight due to the drug, semaglutide.

This drug reportedly works by suppressing appetite, and users apparently crave less and sometimes even forget to eat.

The phenomenal success of the drug has led to rising demand in the US, where about 40% of the population, is reportedly obese.

But apparently, semaglutide is also being prescribed to even those people who are not obese.

‘Styling teams for celebrities have come to accept the injections as part of grooming rituals,’ reports the entertainment magazine Variety. ‘It has become the worst-kept secret in Hollywood.’

The soaring demand has led to stocks of the drug running dry, and the drug’s manufacturer Novo Nordisk UK has established that it is ‘aware of a stock shortage.’

It adds, ‘Unprecedented demand has tested our manufacturing capacity. We are working to remedy this as soon as possible.’

Obesity expert Dr Carel le Roux, Professor of Metabolic Medicine at Ulster University is reported to have said, ‘Without semaglutide, patients relapse – they become incredibly hungry and are drawn to consume more food. They regain weight and their health suffers.’

According to experts, the drug works by mimicking the hormone glucagon-like peptide-1 (GLP-1), which is released after eating.

It signals to the body to release another hormone, known as insulin – this helps move digested sugar from the blood into cells where it can be used for energy, leading to a feeling of being full.

Trials of semaglutide last year caused a stir when it was revealed that patients, on average, lost 16% of their body weight after being on the drug for a year.

This result was reportedly seen even if the patients didn’t change their diet.

A private prescription for the drug costs roughly £100 a month, and many medics are of the opinion that obese patients should be offered the treatment on the NHS before the development of serious conditions such as type 2 diabetes.

‘Obesity is a disease that affects part of the brain involved with feelings of hunger,’ explains Prof le Roux, who runs the campaign group It’s Not Your Fault.

He adds, ‘It’s a biological problem that can’t be controlled with willpower.

‘Semaglutide targets the part of the brain affected by the disease of obesity. Ultimately the goal of treatment is to improve health, not what people see in the mirror.’

Although according to NICE semaglutide can be offered for two years only, Prof le Roux expects this to change.

He reportedly said, ‘There isn’t the evidence yet to show having patients on semaglutide for longer is cost-effective in terms of preventing illness.’

‘Next year we’ll have data to show whether or not the treatment reduces the risk of heart attacks. If it does, there will be a strong argument to put patients on it for life.’

Prof le Roux believes there is currently a shortage of semaglutide due to the staggering number of obese Americans who require it.

However, he warns that those who take this drug to get slim could be shocked by the consequences.

He states, ‘There is a rebound effect when the drug is stopped. Natural levels of GLP-1 will be lower, meaning patients will feel hungrier and end up heavier than before.

This drug will not make someone thin – it’s a treatment for obesity.’

More For You

Covid inquiry begins probe into care home deaths

FILE PHOTO: A mother and daughter sit atop the Covid memorial wall on September 9, 2024 in London, England. (Photo by Carl Court/Getty Images)

Covid inquiry begins probe into care home deaths

THE Covid inquiry has started examining how the pandemic affected care services for older and disabled people, with families describing the crisis as one of the worst failures of the pandemic.

Nearly 46,000 care home residents died with Covid in England and Wales between March 2020 and January 2022, with many deaths happening in the first weeks of the outbreak.

Keep ReadingShow less
Starmer and Glastonbury condemn anti-Israel chants by Bob Vylan

Keir Starmer speaks to members of the media during a visit to RAF Valley, on Anglesey in north-west Wales, on June 27, 2025. PAUL CURRIE/Pool via REUTERS

Starmer and Glastonbury condemn anti-Israel chants by Bob Vylan

PRIME MINISTER Keir Starmer and Glastonbury organisers said on Sunday (29) they were appalled by on-stage chanting against the Israeli military during a performance at the festival by Punk-rap duo Bob Vylan.

During their show on Saturday (28), the duo chanted "Death, death, to the IDF" in reference to the Israel Defense Forces, the formal name of the Israeli military.

Keep ReadingShow less
Pakistan floods

A flooded street near Station Road after heavy rainfall in Hyderabad, Pakistan, on June 27, 2025.

Getty

Pakistan reports 45 deaths from flash floods and rain in monsoon onset

AT LEAST 45 people have died in Pakistan over the past few days due to flash flooding and heavy rainfall since the beginning of the monsoon season, according to disaster management officials on Sunday.

The highest number of deaths was reported in Khyber Pakhtunkhwa province, which borders Afghanistan. There, 21 people were killed, including 10 children.

Keep ReadingShow less
UK Weather Alert: June Heatwave to Hit 34°C, Breaking Records

The UK is bracing for potentially one of the hottest June days on record

iStock

UK set for one of the hottest June days with highs of 34°C

Key points

  • Temperatures may hit 34°C in Greater London and Bedfordshire
  • Amber alert in place across five regions due to health risks
  • Wimbledon’s opening day to be hottest on record
  • Risk of wildfires in London labelled “severe”
  • Scotland and Northern Ireland remain cooler

Hottest June day in years expected as second UK heatwave peaks

The UK is bracing for potentially one of the hottest June days on record, with temperatures expected to reach 34°C on Monday (30 June). The ongoing heatwave, now in its fourth day, is most intense across the South and East of England, particularly in Greater London and Bedfordshire.

Although there is a small chance of temperatures hitting 35°C, they are unlikely to surpass the all-time June record of 35.6°C set in 1976.

Keep ReadingShow less
Air India flight crash
Air India's Boeing 787-8 aircraft, operating flight AI-171 to London Gatwick, crashed into a medical hostel complex shortly after take-off from Ahmedabad on June 12.
Getty Images

Probing all angles in Air India crash, including sabotage: Minister

INDIA’s junior civil aviation minister said on Sunday that all possible angles, including sabotage, were being looked into as part of the investigation into the Air India crash.

All but one of the 242 people on board the Boeing 787-8 Dreamliner were killed when it crashed in Ahmedabad on June 12. Authorities have identified 19 others who died on the ground. However, a police source told AFP after the crash that the death toll on the ground was 38.

Keep ReadingShow less